{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:41:54Z","timestamp":1764290514232,"version":"3.46.0"},"reference-count":62,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_ijamh-2017-0029_s_999\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic syndrome (MS) in adolescents is a risk factor for type 2 diabetes and cardiovascular diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_ijamh-2017-0029_s_998\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The present study aimed to determine the prevalence of MS in 14\u201318-year-old girls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_ijamh-2017-0029_s_997\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This analytical case-control study was conducted on 3200 high school students with polycystic ovarian syndrome (PCOS). PCOS was confirmed by an endocrinologist after detection of clinical hyperandrogenism (acne, hirsutism and alopecia) and oligomenorrhea, rejection of hypothyroidism and hyperprolactinemia and performance of abdominal sonography. In the second stage, the prevalence of MS was compared between 70 girls with PCOS and 45 healthy girls using the ATPIII, Cooki and Ferranti scales. The study data were collected using a demographic questionnaire, body mass index (BMI) graph, the WC graph and standard blood pressure graph in adolescents. Then, the data were analyzed using the t-test and the \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      -test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_ijamh-2017-0029_s_996\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Based on the Ferranti scale, the prevalence of MS was 10.4% and 0% in the case and control groups, respectively. The highest prevalence was related to hyperandrogenism and polycystic ovaries phenotype (11.6% vs. 0%, p = 0.05). Based on the Cooki and ATPIII scales, the prevalence of this disorder was 4.1% in the case group and 0.67% in the control group, with the highest rate being related to hyperandrogenism, oligomenorrhea and polycystic ovaries phenotype (7.5% vs. 0%, p = 0.28).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_ijamh-2017-0029_s_995\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In comparison to the control group, the prevalence of MS in the patients with PCOS was 10-fold higher according to the Ferranti scale and nearly 3.5-fold higher based on the Cooki and ATPIII scales. Thus, long-term follow-up is suggested in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/ijamh-2017-0029","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T06:01:20Z","timestamp":1501912880000},"source":"Crossref","is-referenced-by-count":2,"title":["Metabolic syndrome in Iranian adolescents with polycystic ovary syndrome"],"prefix":"10.1515","volume":"31","author":[{"given":"Mohammad H.","family":"Dabbaghmanesh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine , Endocrine and Metabolism Research Center , Shiraz University of Medical Sciences , Shiraz , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"Naderi","sequence":"additional","affiliation":[{"name":"Department of Midwifery, student research center , School of Nursing and Midwifery , Shiraz University of Medical Sciences , Shiraz , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Akbarzadeh","sequence":"additional","affiliation":[{"name":"Maternal\u2013fetal medicine Research Center , Department of Midwifery, School of Nursing and Midwifery , Shiraz University of Medical Sciences , Nemazee Square, P.O. Box: 71345-1359 , Shiraz , Iran , Phone: +98 711 36474250, Fax: +98 711 3647425"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Tabatabaee","sequence":"additional","affiliation":[{"name":"School of Health , Shiraz University of Medical Sciences , Shiraz , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,8,5]]},"reference":[{"key":"2025112800354126678_j_ijamh-2017-0029_ref_001","doi-asserted-by":"crossref","unstructured":"Franks S. Polycystic ovary syndrom in adolescents. Int J Obes. 2008;32:1035\u201341.","DOI":"10.1038\/ijo.2008.61"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_002","doi-asserted-by":"crossref","unstructured":"Vuguin PM. Interventional studies for polycystic ovarian syndrome in children and adolescents. Ped Health. 2010;4:59\u201373.","DOI":"10.2217\/phe.09.69"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_003","unstructured":"Akbarzadeh M, Naderi T, Dabbaghmaneh MH, Tabatabaee H, Zareh Z. The relationship between clinical and chemical hyperandrogenism in 14\u201318 years of age girls. Zahedan J Res Med Sci (ZJRMS). 2012;14:1\u20137."},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_004","unstructured":"Akbarzadeh M, Moradi F, Dabbaghmanesh MH, Zare N, Parsanezhed ME. Abnormal blood pressure and hyperandrogenemia in first degree relatives of women with polycystic ovarian syndrome referring to gynecology clinics of Shiraz Medical University. Int J Gynaecol Obstet. 2014;2:040\u201344."},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_005","doi-asserted-by":"crossref","unstructured":"Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434\u20138.","DOI":"10.1210\/jc.85.7.2434"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_006","doi-asserted-by":"crossref","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745\u20139.","DOI":"10.1210\/jc.2003-032046"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_007","doi-asserted-by":"crossref","unstructured":"Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol. 2008;139:59\u201364.","DOI":"10.1016\/j.ejogrb.2007.12.018"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_008","doi-asserted-by":"crossref","unstructured":"Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, et al. Prevalence of polycystic ovary syndrome in women in China: a large community based study. Hum Reprod. 2013;28:2562\u20139.","DOI":"10.1093\/humrep\/det262"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_009","doi-asserted-by":"crossref","unstructured":"Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotypes of polycystic ovary syndrome in semiurban population in Srilanka. Am J Epidemiol. 2008;168:321\u20137.","DOI":"10.1093\/aje\/kwn137"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_010","doi-asserted-by":"crossref","unstructured":"Escobar-Morreale HF, San Millan JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18:266\u201372.","DOI":"10.1016\/j.tem.2007.07.003"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_011","doi-asserted-by":"crossref","unstructured":"Bonny AE, Appelbaum H, Connor EL, Cromer B, DiVasta A, Gomez-Lobo V, et al. Clinical variability in approaches to polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2012;25:259\u201361.","DOI":"10.1016\/j.jpag.2012.03.004"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_012","doi-asserted-by":"crossref","unstructured":"Hardy TS, Norman RJ. Diagnosis of adolescent polycystic ovary syndrome. Steroids. 2013;78:751\u20134.","DOI":"10.1016\/j.steroids.2013.04.011"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_013","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_014","doi-asserted-by":"crossref","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456\u2013488.","DOI":"10.1016\/j.fertnstert.2008.06.035"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_015","doi-asserted-by":"crossref","unstructured":"Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203:201.e1\u20135.","DOI":"10.1016\/j.ajog.2010.03.008"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_016","doi-asserted-by":"crossref","unstructured":"McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ, et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab. 2006;91(5):1714\u201322.","DOI":"10.1210\/jc.2005-1852"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_017","doi-asserted-by":"crossref","unstructured":"Fernandes AR, de S\u00e1 Rosa e Silva AC, Rom\u00e3o GS, Pata MC, dos Reis RM. Insulin resistance in adolescents with menstrual irregularities. J Pediatr Adolesc Gynecol. 2005;18:269\u201374.","DOI":"10.1016\/j.jpag.2005.05.006"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_018","doi-asserted-by":"crossref","unstructured":"Bridges NA, Cooke A, Healy MJ, Hindmarsh PC, Brook CG. Standards for ovarian volume in childhood and puberty. Fertil Steril. 1993;60:456\u201360.","DOI":"10.1016\/S0015-0282(16)56160-3"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_019","doi-asserted-by":"crossref","unstructured":"Mortensen M, Rosenfield RL, Littlejohn E. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006;91:3786\u201390.","DOI":"10.1210\/jc.2006-0835"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_020","doi-asserted-by":"crossref","unstructured":"Blank SK, Helm KD, McCartney CR, Marshall JC. Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci. 2008;1135:76\u201384.","DOI":"10.1196\/annals.1429.005"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_021","doi-asserted-by":"crossref","unstructured":"van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril. 2000;74:49\u201358.","DOI":"10.1016\/S0015-0282(00)00584-7"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_022","doi-asserted-by":"crossref","unstructured":"Arslanian S, Warren-Ulanch J. Treatment of PCOS in adolescence. Best Pract Res Clin Endocrinol Metab. 2006;20:311\u201330.","DOI":"10.1016\/j.beem.2006.02.002"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_023","doi-asserted-by":"crossref","unstructured":"Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinalmetab. 2006;91:393\u20135.","DOI":"10.1210\/jc.2005-1666"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_024","doi-asserted-by":"crossref","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18:618\u201337.","DOI":"10.1093\/humupd\/dms030"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_025","doi-asserted-by":"crossref","unstructured":"Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004;4:53\u201362.","DOI":"10.1007\/s11892-004-0012-x"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_026","doi-asserted-by":"crossref","unstructured":"Jessup A, Harrell JS. The metabolic syndrome: look for it in children and adolescents, too!. Clin Diabetes. 2005;23:26\u201332.","DOI":"10.2337\/diaclin.23.1.26"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_027","doi-asserted-by":"crossref","unstructured":"Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril. 2009;92:626\u201334.","DOI":"10.1016\/j.fertnstert.2008.06.004"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_028","doi-asserted-by":"crossref","unstructured":"Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod. 2005;20:2409\u201313.","DOI":"10.1093\/humrep\/dei100"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_029","doi-asserted-by":"crossref","unstructured":"Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents: the IDF consensus. Diabetes Voice. 2007;52:29\u201331.","DOI":"10.1111\/j.1399-5448.2007.00271.x"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_030","doi-asserted-by":"crossref","unstructured":"Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059\u201361.","DOI":"10.1016\/S0140-6736(07)60958-1"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_031","doi-asserted-by":"crossref","unstructured":"Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up?. J Pediatr. 2008;152:160.e13\u2013164.e13.","DOI":"10.1016\/j.jpeds.2007.07.056"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_032","doi-asserted-by":"crossref","unstructured":"Hashemipour M, Faghihimani S, Zolfaghary B, Hovsepian S, Ahmadi F, Haghighi S. Prevalence polycystic ovary syndrome in girls aged 14\u201318 years in Isfahan, Iran. Horm Res. 2004;62:278\u201382.","DOI":"10.1159\/000081842"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_033","doi-asserted-by":"crossref","unstructured":"Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, et al. Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet. 1985;2:1375\u201379.","DOI":"10.1016\/S0140-6736(85)92552-8"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_034","doi-asserted-by":"crossref","unstructured":"Akbarzadeh M, Naderi T, Dabbaghmanesh MH, zare N, Zare Z. The survey of cutaneous manifestations in adolescents suffering from poly cystic ovarian syndrome. Asian J Dermatol. 2013;5:11\u201321.","DOI":"10.3923\/ajd.2013.11.21"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_035","unstructured":"National Cholesterol Education Panel. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Bethesda, MD: National Institutes of Health, 1991 NIH Publication No. 91-2732."},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_036","doi-asserted-by":"crossref","unstructured":"Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American and Mexican-American children and adolescents. J Pediatr. 2004;145:439\u201344.","DOI":"10.1016\/j.jpeds.2004.06.044"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_037","doi-asserted-by":"crossref","unstructured":"Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996;98:649\u201358.","DOI":"10.1542\/peds.98.4.649"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_038","unstructured":"National Heartm, Lung and Blood Institute. The Lipid Research Clinics population studies data book, Volume I: the prevalence study. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication, 1980:80\u20131527."},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_039","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus (Position statement). Diabetes Care. 2004;27:S5\u2013S10.","DOI":"10.2337\/diacare.27.2007.S5"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_040","doi-asserted-by":"crossref","unstructured":"Duncon GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome Phenotype among US adolescents, 1999\u20132000. Diabetes care. 2004;27:2438\u201343.","DOI":"10.2337\/diacare.27.10.2438"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_041","doi-asserted-by":"crossref","unstructured":"Bitsori M, Kafatos A. Dysmetabolic syndrome in childhood and adolescence. Acta Paediatr. 2005;94:995\u20131005.","DOI":"10.1111\/j.1651-2227.2005.tb02034.x"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_042","doi-asserted-by":"crossref","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415\u201328.","DOI":"10.1016\/S0140-6736(05)66378-7"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_043","doi-asserted-by":"crossref","unstructured":"Huang TT, Sun SS, Daniels SR. Understanding the nature of metabolic syndrome components in children and what they can and cannot do to predict adult disease. J Pediatr. 2009;155:e13\u20134.","DOI":"10.1016\/j.jpeds.2009.04.043"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_044","doi-asserted-by":"crossref","unstructured":"Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650\u20136.","DOI":"10.1056\/NEJM199806043382302"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_045","doi-asserted-by":"crossref","unstructured":"Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics. 2007;120:340\u20135.","DOI":"10.1542\/peds.2006-1699"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_046","doi-asserted-by":"crossref","unstructured":"Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004;4:53\u201362.","DOI":"10.1007\/s11892-004-0012-x"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_047","doi-asserted-by":"crossref","unstructured":"de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494\u20137.","DOI":"10.1161\/01.CIR.0000145117.40114.C7"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_048","doi-asserted-by":"crossref","unstructured":"Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005;82:1046\u201351.","DOI":"10.1093\/ajcn\/82.5.1046"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_049","doi-asserted-by":"crossref","unstructured":"Seo SJ, Lee HY, Lee SW. The prevalence of the metabolic syndrome in Korean children and adolescents: comparisons of the criteria of Cook et al., Cruz and Goran, and Ferranti et al. Yonsei Med J. 2008;49(4):563\u201372.","DOI":"10.3349\/ymj.2008.49.4.563"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_050","doi-asserted-by":"crossref","unstructured":"Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc. 2002;287:356\u20139.","DOI":"10.1001\/jama.287.3.356"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_051","doi-asserted-by":"crossref","unstructured":"Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol. 2006;154:141\u20135.","DOI":"10.1530\/eje.1.02058"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_052","doi-asserted-by":"crossref","unstructured":"Rahmanpour H, Jamal L, Mousavinasab SN, Esmailzadeh A, Azarkhish K. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents. J Pediatr Adolesc Gynecol. 2012;25:208\u201312.","DOI":"10.1016\/j.jpag.2012.02.004"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_053","doi-asserted-by":"crossref","unstructured":"Erica W, Lorraine L. Public health metabolic syndrome: waist not want. Can Med Assoc J. 2004;170:1503.","DOI":"10.1503\/cmaj.1040423"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_054","unstructured":"Jana P, Andrew H. Childhood obesity preventive and treatment, 1st ed London: CRC, Press, 2001:30."},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_055","doi-asserted-by":"crossref","unstructured":"Morrison JA, Friedman LA, Harlan WR, Harlan LC, Barton BA, Schreiber GB, et al. Development of the metabolic syndrome in black and white adolescent girls: a longitudinal assessment. Pediatrics. 2005;116:1178\u201382.","DOI":"10.1542\/peds.2004-2358"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_056","doi-asserted-by":"crossref","unstructured":"Dehghan M, Akhtar-Danesh N, Merchant AT. Childhood obesity, prevalence and prevention. Nutr J. 2005;4:24.","DOI":"10.1186\/1475-2891-4-24"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_057","doi-asserted-by":"crossref","unstructured":"Py\u00f6r\u00e4l\u00e4 M, Miettinen H, Laakso M, Py\u00f6r\u00e4l\u00e4 K. Hyperinsulinemia predicates coronary heart disease risk in healthy middle aged men: the 22 year follow-up results of the Helsinki policemen study. Circulation. 1998;98:398\u2013404.","DOI":"10.1161\/01.CIR.98.5.398"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_058","doi-asserted-by":"crossref","unstructured":"Braga-Tavares H, Fonseca H. Prevalence of metabolic syndrome in a Portuguese obese adolescent population according to three different definitions. Eur J Pediatr. 2010;169:935\u201340.","DOI":"10.1007\/s00431-010-1143-5"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_059","doi-asserted-by":"crossref","unstructured":"Park J, Hilmers DC, Mendoza JA, Stuff JE, Liu Y, Nicklas TA. Prevalence of metabolic syndrome and obesity in adolescents aged 12 to 19 years: comparison between the United States and Korea. J Korean Med Sci. 2010;25:75\u201382.","DOI":"10.3346\/jkms.2010.25.1.75"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_060","doi-asserted-by":"crossref","unstructured":"Rehme MF, Pontes AG, Goldberg TB, Corrente JE, Pontes A. Clinical manifestations, biochemical, ultrasonographic and metabolic of polycystic ovary syndrome in adolescents. Rev Bras Ginecol Obstet. 2013;35:249\u201354.","DOI":"10.1590\/S0100-72032013000600003"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_061","doi-asserted-by":"crossref","unstructured":"Bhattacharya SM, Jha A. Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 \u2018joint interim criteria\u2019. J Obstet Gynaecol Res. 2011;37:1303\u20137.","DOI":"10.1111\/j.1447-0756.2010.01516.x"},{"key":"2025112800354126678_j_ijamh-2017-0029_ref_062","unstructured":"Akbarzadeh M, Moradi F, Dabbagh Manesh MH, Zareh N, Parsa Nezhad ME. Insulin resistance in first-degree relatives of the patients with polycystic ovarian syndrome. IJDO. 2013;5(4):163\u201370."}],"container-title":["International Journal of Adolescent Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/ijamh.2019.31.issue-4\/ijamh-2017-0029\/ijamh-2017-0029.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/ijamh-2017-0029\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/ijamh-2017-0029\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:37:32Z","timestamp":1764290252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/ijamh-2017-0029\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,5]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,1,13]]},"published-print":{"date-parts":[[2019,8,27]]}},"alternative-id":["10.1515\/ijamh-2017-0029"],"URL":"https:\/\/doi.org\/10.1515\/ijamh-2017-0029","relation":{},"ISSN":["2191-0278"],"issn-type":[{"type":"electronic","value":"2191-0278"}],"subject":[],"published":{"date-parts":[[2017,8,5]]},"article-number":"20170029"}}